What is the NOAEL for Octrizole?
Octrizole has 8 NOAEL studies in the database. The lowest reported value is 0.7 mg/m3 via inhalation in Human. Source: ToxValDB_GESTIS_DNEL.
Also known as: Phenol, 2-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)-, EINECS 221-573-5, Viosorb 583, Tinuvin 329, Sumisorb 340 (+15 more)
CAS 3147-75-9
Octrizole (CAS 3147-75-9) is a chemical substance; key hazard signal: vPvB (Article 57e). Key regulatory status: SVHC Candidate List, REACH registered, 7 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from EPA ToxValDB, EPA CPDat, AICIS, ECHA REACH, ECHA SVHC.
CAS, identifiers, formula, and alternate names for the matched substance record.
Candidate List status and reason under the ECHA REACH SVHC program.
| Substance | Reason | Included |
|---|---|---|
| 2-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol (UV-329) | vPvB (Article 57e) | 23-Jan-2024 |
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| IFRA Transparency | IFRA | IFRA |
| consumer_product | P&G | Proctor & Gamble |
| inert_ingredient; non_food_use; Pesticides | EPA | CPCat |
| CEDI | FDA | United States Food and Drug Administration (FDA) |
| Indirect additives food contact (10/2018) | FDA | United States Food and Drug Administration (FDA) |
| Europe; plastic_additive | European Chemicals Agency | European Chemicals Agency (ECHA) |
| pharmaceutical | US International Trade Commission | CPCat |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 5.87 | uL/min/10^6 cells | Clint | - | Human | NTP_ICE_adme_parameters |
| =0.7 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB_GESTIS_DNEL |
| R775Y233N3 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| R775Y233N3 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| R775Y233N3 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| R775Y233N3 | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 0.0223 | fraction | Fu | - | Human | NTP_ICE_adme_parameters |
| - | unitless | Model Score | - | - | NTP_ICE_endocrine |
Showing 8 of 8 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | 2-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol | 221-573-5 | ECHA overview → |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Octrizole has 8 NOAEL studies in the database. The lowest reported value is 0.7 mg/m3 via inhalation in Human. Source: ToxValDB_GESTIS_DNEL.
Octrizole appears on 7 regulatory/inventory lists including IFRA Transparency, consumer_product, inert_ingredient; non_food_use; Pesticides, and 4 more. Source: EPA CPDat.
Yes, Octrizole is listed on the ECHA REACH Candidate List as a Substance of Very High Concern. Reason: vPvB (Article 57e). Source: ECHA SVHC Candidate List.
Yes, Octrizole is also indexed as a cosmetic ingredient under the name OCTRIZOLE. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, ECHA SVHC Candidate List, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Octrizole also appears in cosmetics, pharmaceutical databases.